Participants, who underwent two glucagon dosing visits that were 1 to 4 weeks apart, were randomly assigned 3 mg intranasal glucagon or 1 mg intramuscular during the first dosing visit, with the ...

The intramuscular or subcutaneous injection of 1 or 2 mg. of glucagon* is easier and more convenient than the intravenous administration of glucose in the unconscious or uncooperative patient ...

An investigational intranasal glucagon product may treat hypoglycemia just as effectively as intramuscular injections, a new study of adults with type 1 diabetes suggests. The intranasal glucagon ...

Nasal glucagon was noninferior to intramuscular glucagon for treating hypoglycemia in Japanese adults with type 1 or type 2 diabetes, according to findings published in Diabetes, Obesity and ...

Lilly's investigational nasal glucagon was equally effective and safe as the injected formulation in reversing severe hypoglycemia in type 1 diabetes; it may prove simpler to use in stressful ...

The response to the intramuscular injection of 5 mg. of zinc glucagon on the blood sugar concentration is shown in Figure 1.A single injection of the drug prevented hypoglycemia during at least 8 ...

Source Reference: Sherr J, et al "Glucagon nasal powder: An effective alternative to intramuscular glucagon in youth with type 1 diabetes" ADA 2015. Share on Facebook. Opens in a new tab or window ...

Glucagon can also play a role in how amino acids (compounds that help make up muscles and tissue in your body) make glucose. And it can break down triglycerides, or fat your body stores, into fuel.

All but one intranasal visit (98.7%) and all intramuscular visits (100%) met success criteria (increase in plasma glucose to ≥70 mg/dL or ≥20 mg/dL from the glucose nadir within 30 minutes ...